Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2019 07:00 ET | Source: Immuron Limited

US Department of Defense Reports Final Results from Travelan® Shigellosis Challenge Study

Key Highlights: Travelan® shigellosis challenge studies in non-human primates successfully completedTravelan® prevented clinical shigellosis (bacillary dysentery) in 75% of Travelan® treated animals...
May 07, 2018 21:43 ET | Source: Immuron Limited

Immuron Reports Significant Alleviation of Colitis Symptoms in Preclinical Program

MELBOURNE, Australia, May 07, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally...